References

  1. Epidemiology and Morbidity. Diabetes and Impaired Glucose Tolerance Global Burden: Prevalence and Projections, 2010 and 2030. Brussels. 2006. International Diabetes Federation: The Diabetes Atlas. Google Scholar

  2. Hall Victoria, Thomsen Reimar, Henriksen Ole, Lohse Nicolai. Diabetes in Sub Saharan Africa 1999-2011:Epidemiology and public health implications. A systemic review. BMC Public Health. 2011; 11:564. PubMed | Google Scholar

  3. Sicree Richard, Shaw Jonathan, Zimmet Paul. The Global Burden: Diabetes and Impaired GlucoseTolerance (Diabetes Atlas, 4thEdition). 2009. Brussels. International Diabetes Federation. Google Scholar

  4. McLarty Donald, Unwin N, Kitange HM, Alberti George. Diabetes mellitus as a cause of death in Sub-Saharan Africa:results of community-based study in Tanzania: The adult morbidity and Mortality Project. Diabet Med .1996;13(11): 990-4. PubMed | Google Scholar

  5. International Diabetes Federation. Diabetes Declaration and Strategy for Africa: Press Release. 2006. Cape Town, South Africa. International Diabetes Federation. Google Scholar

  6. Duràn-Varela Blanca , Rivera-Chavira B, Franco-Gallegos E. Pharmacological therapy compliance in diabetes. Salud Publica Mexico. 2001; 43(3):233-236. PubMed | Google Scholar

  7. Swaby Peter, Wilson E, Swaby S, Sue-Ho R, Pierre Russel. Chronic diseases control and compliance. The HOPE, worldwide Jamaica's experience. PNG Med J. 2001;44(3-4):171-175. PubMed | Google Scholar

  8. McCabe Bhrett. Barriers to adherence in a free medication program for low income individuals with type 2 diabetes (Ph.D). 1999. Louisiana, USA. Louisiana State University. PubMed | Google Scholar

  9. Schectman Joel, Nadkarni MM, Voss John. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002;25(6):1015-1021. PubMed | Google Scholar

  10. Shobhana Ramachandran, Begum R, Snehalatha C, Vijay V, Ramachandran Ambady. Patients' adherence to diabetes treatment. J Assoc Physicians India. 1999;47(12):1173-1175. PubMed | Google Scholar

  11. Rubin Richard. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med. 2005;118(5):27-34. PubMed | Google Scholar

  12. Ciechanowski Paul, Katon WJ, Russo Joan. Depression and diabetes:impact of depressive symptoms on adherence, functions and costs. Arch Intern Med. 2000;160(21):3278-3285. PubMed | Google Scholar

  13. Melikian Caron, Vanderplas A, Dezil CM, Chang Eunice. Adherence to oral diabetic therapy in a managed care organization.A comparison of monotherapy, combination therapy and fixed dose combination. Clinical therapeutics. 2002;24(3):460-467. PubMed | Google Scholar

  14. Tiv Michel, Viel J-F, Mauny F, Eschwége E, Weill A, Fournier C, et al. Medication adherence in Type 2 Diabetes: The ENTRED Study 2007, a French Population-Based Study.PLoSONE.2012;7(3):e32412. PubMed | Google Scholar

  15. clar David, Robison LM, Skaer TL, Dickson MW, Kozma CM, Reeder Eugene. Sulfonylurea pharmacotherapy regimen adherence in Medicaid population:Influence of age, gender and race.Diabetes Educ .1999;25(4):531-532, 535, 537-538. PubMed | Google Scholar

  16. Donnan Peter, MacDonald TM, Morris Andrew.Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes. A retrospective cohort study. Diabetes Med. 2002;19(4):279-284. PubMed | Google Scholar

  17. Osterberg Lars, Blaschke Terrence. Adherence to medication. N Engl J Med. 2005;353(5):487-497. PubMed | Google Scholar

  18. Vermeire Etienne, Wens J, Van Royen P, Biot Y, Hearnshaw H, Lindenmeyer Antje. Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. 2005;(2).Art No.: CD003638. PubMed | Google Scholar

  19. Kalyango Joan, Owino E, Nambuya Agatha. Non-adherence to diabetes treatment at Mulago hospital in Uganda: prevalence and associated factors. Afr Health Sci. 2008;8(2):67-73. PubMed | Google Scholar

  20. Grant Richard, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003;26(5):1408-1412. PubMed | Google Scholar

  21. Horne Robert, Weinman John. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47(6):555-567. PubMed | Google Scholar

  22. Heloisa Gimenes, Zannetti ML, Vanderlei Haas. Factors related to patient adherence to antidiabetic therapy. Revista Latino-American de Enfermagem. 2009;17(1). PubMed | Google Scholar

  23. Chapman Richard, Benner JS, Petrilla AA, Tierce JC, Collins R, Battleman David, et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005;165(10):1147-1152. PubMed | Google Scholar

  24. Sud Anchal, Kline-Rogers EM, Eagle KA, Fang J, Armstrong D, Rangarajan Krishna, , et al. Adherence to medications by patients after acute coronary syndromes. Ann Pharmacother. 2005;39(11):1792-1797. PubMed | Google Scholar

  25. Yusuff Kazeem, Obe , Joseph Bonatson. Adherence to anti-diabetic drug therapy and self-management practices among type-2 diabetics in Nigeria. Pharm World Sci. 2008;30(6):876-883. PubMed | Google Scholar

  26. Goldman Dana, Joyce GF, Escarce JJ, Pace JE, Solomon MD, Laouri Marianne, et al. Pharmacy benefits and the use of drugs by chronically ill. JAMA. 2004;291(19):2344-2350. PubMed | Google Scholar

  27. Martin Bradley, McMillan John. The impact of implementing a more restrictive prescription limit on Medicaid recipients.Effects on costs, therapy and out-of-pocket expenditures. Med Care. 1996;34(7):686-701. PubMed | Google Scholar

  28. Sackett David, Guyatt Gordon , Hayness Brian, Tugwell Peter. Clinical Epidemiology.A basic science for clinical medicine; Textbook of Clinical Epidemiology. 1991. Boston, Mass. Little, Brown and Company.

  29. Dunbar-Jacob Sereika, Rohay Jeffrey, Burke Lora. Electronic methods in assessing medical regimens. 1998. Mahwah, New Jersey. Lawrence Erlbaum Associates.

  30. World Health Organization. Physical status:the use and interpretation of anthropometry. 1995. Geneva. WHO Technical Report Series 854.

  31. Herman William, Kennedy Laurence. Underdiagnosis of Peripheral neuropathy in Type 2 diabetes. American Diabetes Association: Diabetes Care. 2005; 28(6): 1480-1481. PubMed | Google Scholar

  32. American Diabetes Association. Preventive foot care in people with diabetes (Positional Statement). Diabetes Care. January 2002; 25(1): s69-s70. PubMed | Google Scholar

  33. Rooke Thom, Hirsch Alan, Misra Sanjay, Sidawy Anton, Beckman Joshua, Findeiss Laura. 2011 ACCF/AHA Focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology.2011; 58(19): 2020-2045. PubMed | Google Scholar

  34. Chobanian Army, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Joseph, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003; 42(6):1206-1252. PubMed | Google Scholar

  35. Goldstein David, Litle RR, Lorenz RA, Malone JI, Nathan DM, Peterson Charles. American Diabetes Association: Tests of Glycemia in Diabetes. Diabetes Care. 2003; 26(suppl 1):S106-108. PubMed | Google Scholar

  36. International Diabetes Federation. Clinical Guidelines Task Force, Glucose control levels, Global Guideline for Type 2 Diabetes. 2005. Brussels, Belgium. International Diabetes Federation. Google Scholar

  37. Monnier Louis, Colette Claude. Target for Glycemic control concentrating onglucose. Diabetes care. 2009; 32(suppl 2):S199-S204. PubMed | Google Scholar

  38. Diamond Jared. The double puzzle of diabetes. Nature. 2003;423(6940):599-602. PubMed | Google Scholar

  39. Grant Richard, Adams AS, Trinacty CM, Zhang F, Kleinman K, Soumerai Stephen et al. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care. 2007;30(4):807-812. PubMed | Google Scholar

  40. Lin Elizabeth, Katon W, Von Korff Ml, Rutter C, Simon GE , Oliver Malia, et al. Relationship of Depression and Diabetes Self-care, Medication Adherence and Preventive Care. Diabetes Care. 2004;27(9):2154-2160. PubMed | Google Scholar

  41. Glasgow Russell, McCaul KD, Schafer Lorraine. Self-care behaviours and glycemic control in type 1 diabetes. J Chronic Disease. 1987; 40(5):399-412. PubMed | Google Scholar

  42. Kravitz Richard, Hays RD, Sherbourne CD, DiMatteo RM, Rogers WH, Ordway Lyn, et al. Recall of recommendations and adherence to advise among patients with chronic medical conditions. Arch Intern Med. 1993; 153(16):1869-1878. PubMed | Google Scholar

  43. Hays Ron, Kravitz RL, MazelRM, SherbourneCD, DiMatteo RM, Rogers William, et al.The impact of patient adherence on health outcomes for patients with chronic disease in medical outcomes study. J Behav Med. 1994; 17(4):347-360. PubMed | Google Scholar

  44. Phillips Lawrence, Branch WT, CookCB, Doyle JP, El-Kebbi IM, Gallina Daniel, et al. Clinical inertia. Ann Intern Med. 2001; 135:825-834. PubMed | Google Scholar

  45. Mann Devin, Ponieman D, Leventhal H, Halm Ethan. Predictors of adherence to diabetes medications: the role of disease and medication beliefs. J Behav Med .2009; 32(3):278-284. PubMed | Google Scholar